Here are four things to know about the survey, which was launched in May:
- About 5 percent of survey participants reported spending more than $5,000 a month on cancer drugs. More than 10 percent reported spending between $1,000 and $4,999 a month.
- Nearly 20 percent of respondents or their family members have been living with cancer for more than 10 years.
- Approximately 35 percent of respondents said they receive financial support from an assistance program.
- Around 9 percent of participants reported being denied assistance.
More articles on cancer drugs:
Why this cancer drug is being fast-tracked for FDA approval
Protestors at ‘right to try’ rally in D.C. want access to experimental drugs
Novartis pledges to triple biosimilar drugs in market by 2020
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
